Cytosorbents Corp
General ticker "CTSO" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $49.8M
Cytosorbents Corp follows the US Stock Market performance with the rate: 11.5%.
Estimated limits based on current volatility of 4.6%: low 0.84$, high 0.92$
Factors to consider:
- Current price 15.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.06$, 2.78$]
- 2024-12-30 to 2025-12-30 estimated range: [1.30$, 3.22$]
Financial Metrics affecting the CTSO estimates:
- Negative: Non-GAAP EPS, $ of -0.64 <= 0.10
- Negative: Operating profit margin, % of -46.20 <= 1.03
- Negative: Operating cash flow per share per price, % of -24.70 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Positive: Inventory ratio change, % of 1.07 <= 1.08
- Positive: Interest expense per share, $ of 0 <= 0.14
Short-term CTSO quotes
Long-term CTSO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $43.17MM | $34.69MM | $36.35MM |
| Operating Expenses | $65.91MM | $66.21MM | $67.56MM |
| Operating Income | $-22.74MM | $-31.52MM | $-31.21MM |
| Non-Operating Income | $-2.55MM | $-2.38MM | $1.89MM |
| Interest Expense | $0.00MM | $0.13MM | $0.16MM |
| R&D Expense | $16.38MM | $15.12MM | $15.73MM |
| Income(Loss) | $-25.29MM | $-33.91MM | $-29.32MM |
| Taxes | $-0.74MM | $-1.09MM | $-0.81MM |
| Profit(Loss) | $-24.56MM | $-32.81MM | $-28.51MM |
| Stockholders Equity | $62.58MM | $35.37MM | $23.28MM |
| Inventory | $4.77MM | $3.46MM | $3.68MM |
| Assets | $89.52MM | $63.23MM | $53.26MM |
| Operating Cash Flow | $-14.01MM | $-28.23MM | $-21.66MM |
| Capital expenditure | $4.28MM | $6.46MM | $0.94MM |
| Investing Cash Flow | $-4.28MM | $-6.46MM | $-0.94MM |
| Financing Cash Flow | $0.72MM | $4.96MM | $14.47MM |
| Earnings Per Share* | $-0.57 | $-0.75 | $-0.64 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.